If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,096.00    -22.00 (-1.97%)
Bid:
1,094.00
Ask:
1,098.00
Spread: 4.00 (0.366%)
Market Cap: £375.24m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

17 Nov 2020 07:00

RNS Number : 4950F
Craneware plc
17 November 2020
 

17 November 2020

 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement

 

 

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting taking place at 10am today. The AGM will be run as a "closed meeting", with only the minimum required quorum of two shareholders being present as is necessary to enable the formal business of the meeting to be conducted.

 

The first four months of this fiscal year saw a return to strong sales growth, considerably ahead of the equivalent period of the prior year. Results are ahead of management expectations for this stage in the year and, we expect revenues and adjusted EBITDA for the Interim period to 31 December 2020 to be ahead of the equivalent period in the prior year, building the foundation for a return to double-digit growth in the future. We look forward to providing further details within our Trading Update for the 6 months ended 31 December 2020.

 

Our Value Cycle offering, delivered via our cloud-based Trisus platform, continues to resonate with the leadership teams of US hospitals. Trisus provides the means to collect, analyse, compare, verify, and correct their data, so they can improve the financial and operational performance of their hospitals, while improving patient outcomes.

 

With each hospital that joins the platform, Trisus becomes more powerful. Through the recent beta launches of the Trisus (cloud) versions of our core offerings, Chargemaster Toolkit and Pharmacy Chargelink, and our four live Trisus native cloud applications, we now have multiple means by which new and existing customers can join the Trisus Community, providing them with a gateway to the wider benefits the platform can provide.

 

We continue to see substantial new opportunities entering the sales pipeline and the Board is confident in the continued strong performance of the business.

 

 For further information, please contact:

Craneware plc

Peel Hunt 

Investec Bank

Alma

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Robyn Fisher

Andrew Clark

Henry Reast

Helena BogleJoe Pederzolli

About Craneware

 

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBIBDBLGBDGGL
Date   Source Headline
4th Sep 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSesMD Certification
15th Aug 20127:00 amRNSNotice of Results
2nd Aug 20122:58 pmRNSHolding(s) in Company
2nd Jul 20127:00 amRNSTrading Update
15th Jun 201210:57 amRNSTotal Voting Rights
31st May 201212:32 pmRNSHolding(s) in Company
29th May 20121:03 pmRNSHolding(s) in Company
28th May 20124:14 pmRNSHolding(s) in Company
28th May 20124:11 pmRNSHolding(s) in Company
8th May 20125:41 pmRNSHolding(s) in Company
27th Apr 20125:09 pmRNSHolding(s) in Company
26th Apr 20124:17 pmRNSHolding(s) in Company
26th Apr 20123:46 pmRNSHolding(s) in Company
23rd Apr 20126:14 pmRNSTotal Voting Rights
23rd Apr 20126:13 pmRNSBlocklisting Interim Review
16th Apr 201212:57 pmRNSHolding(s) in Company
30th Mar 201212:36 pmRNSHolding(s) in Company
29th Mar 20125:02 pmRNSHolding(s) in Company
28th Mar 20123:39 pmRNSHolding(s) in Company
20th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20125:51 pmRNSDividend Currency Election
8th Mar 201212:57 pmRNSHolding(s) in Company
5th Mar 201212:17 pmRNSTotal Voting Rights
2nd Mar 20123:24 pmRNSHolding(s) in Company
29th Feb 20125:43 pmRNSHolding(s) in Company
28th Feb 20124:29 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSChannel Partner Contract Win
28th Feb 20127:00 amRNSHalf Yearly Report
17th Feb 20123:29 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSNotice of Results
31st Jan 201210:00 amRNSHolding(s) in Company
16th Jan 20123:40 pmRNSHolding(s) in Company
12th Jan 20126:28 pmRNSHolding(s) in Company
11th Jan 20124:55 pmRNSHolding(s) in Company
10th Jan 20127:00 amRNSTrading Update
11th Nov 20111:14 pmRNSDividend Currency Election
10th Nov 201110:36 amRNSResult of AGM
10th Nov 20117:00 amRNSAGM Statement
1st Nov 20115:39 pmRNSTotal Voting Rights
1st Nov 201112:29 pmRNSBlocklisting Interim Review
25th Oct 20111:42 pmRNSDirector/PDMR Shareholding
18th Oct 20112:26 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20114:43 pmRNSTotal Voting Rights
26th Sep 20117:00 amRNSGrant of Options
31st Aug 201111:53 amRNSDirector/PDMR Shareholding
30th Aug 20117:00 amRNSFinal Results
22nd Aug 20115:02 pmRNSHolding(s) in Company
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.